Download
https://www.ndtvprofit.com/business/analysts-say-lupin-cipla-may-benefit-from-perrigos-asthma-drug-recall?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Both Lupin and Cipla had earlier this year received U.S. FDA approval for marketing ashthma drugs in the United States.
Share